Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis.

A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. Mult Scler. 2005 Oct; 11(5):552-61.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.